文献速递关节外科

初次与翻修关节置换术相关的不良心脏事件

Adverse cardiac events associated with primary and revision arthroplasty.
PubMed 文献 · Bone Joint J · 2025-08-01

该研究为BASEL-PMI试验的事后分析,纳入673例接受初次或翻修全髋/全膝关节置换术的患者。结果显示翻修术患者围术期心肌损伤、主要不良心脏事件和死亡率均高于初次置换,其中假体周围感染翻修者风险最高。

要点

  • 翻修术患者围术期心肌损伤发生率为21%(无菌性翻修)和35%(假体周围感染翻修),高于初次置换的12%。
  • 假体周围感染翻修患者全因死亡率为9%,高于无菌性翻修的4%和初次置换的2%。
  • 多变量分析显示假体周围感染翻修患者围术期心肌损伤的比值比为2.9(95% CI 1.7至5.2)。

核心结论

  • 接受翻修关节置换术的患者相比初次置换术患者,围术期心肌损伤、主要不良心脏事件和死亡率风险显著增加。
  • 在翻修手术中,因假体周围感染行翻修术的患者心血管并发症风险尤其高。

研究设计与样本

  • 本研究为BASEL-PMI研究(NCT02573532)的事后分析。
  • 研究纳入来自一家三级医疗中心的673例患者,均接受初次全髋或全膝关节置换术、或翻修全髋和全膝关节置换术。
  • 纳入标准为存在明确心血管合并症或年龄≥65岁,且符合本机构围术期心肌损伤筛查与响应方案的资格。
  • 术前及术后第1天和第2天测量高灵敏度心肌肌钙蛋白T水平。
  • 主要终点为围术期心肌损伤的发生率,次要终点包括术后120天全因死亡率和主要不良心脏事件发生率。

主要发现

  • 2014年5月至2018年2月期间共纳入673例患者,其中443例接受初次全髋或全膝关节置换术,111例接受无菌性翻修术,119例因假体周围感染接受翻修术。
  • 围术期心肌损伤总体发生于120例患者(18%),其中无菌性翻修组23例(21%),假体周围感染翻修组42例(35%),初次关节置换组55例(12%)。
  • 因假体周围感染行翻修术的患者全因死亡率为9%,显著高于无菌性翻修组的4%和初次关节置换组的2%。
  • 翻修术患者的主要不良心脏事件发生率也升高,尤其是因假体周围感染行翻修术者(12%)。
  • 多变量分析显示,因假体周围感染行翻修术的患者发生围术期心肌损伤的比值比为2.9(95% CI 1.7至5.2)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to analyze the risk of perioperative adverse outcomes, including perioperative myocardial injury and infarction (PMI), major adverse cardiac events (MACE), and mortality, which are associated with revision for periprosthetic joint infection (PJI) compared with primary arthroplasty and aseptic revision surgery. METHODS: This was a post-hoc analysis of the BASEL-PMI study (NCT02573532). The study included patients from one tertiary care centre who underwent primary total hip (THA) or knee (TKA) arthroplasty, and revision THA and TKA. Patients were included if they had established cardiovascular comorbidities or were aged ≥ 65 years, and were eligible for our institutional PMI screening and response programme. High-sensitivity cardiac troponin T levels were measured preoperatively and on postoperative days one and two. The primary endpoint was the incidence of PMI, and secondary endpoints included the rates of all-cause mortality and MACE at 120 days postoperatively. RESULTS: Between May 2014 and February 2018, 673 patients were included in the study, of whom 443 underwent primary THA or TKA, 111 underwent aseptic revision, and 119 underwent revision for PJI. PMI occurred in 120 patients (18%) overall, with higher rates in revisions (23; 21%) in the aseptic and 42 (35%) in the PJI groups) compared with 55 (12%) in the primary arthroplasty group. All-cause mortality was significantly increased in patients who underwent revision for PJI (9%) compared with aseptic revision (4%) and primary arthroplasty (2%). The rates of MACE were also increased in revisions, particularly in those for PJI (12%). Multivariable analysis showed an odds ratio of 2.9 (95% CI 1.7 to 5.2) for PMI in revisions for PJI. CONCLUSION: Patients who underwent revision arthroplasty had significantly increased risks of PMI, MACE, and mortality compared with those who underwent primary arthroplasty. In revision surgery, revision for PJI showed an especially high risk of cardiovascular complications.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Puelacher C, Stuetzle A, Morgenstern M, et al. Adverse cardiac events associated with primary and revision arthroplasty. Bone Joint J. 2025. PMID: 40746101. doi:10.1302/0301-620X.107B8.BJJ-2025-0048.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。